2,543 results on '"*SCLEROTHERAPY"'
Search Results
2. A New Radiological Scoring System as a Method of Assessing Sclerotherapy Treatment Response for Aneurysmal Bone Cysts: A Retrospective Study.
- Author
-
Hussein, Mohsin, Davies, Mark, Hegde, Ganesh, Azzopardi, Christine, Patel, Anish, James, Steve, and Botchu, Rajesh
- Subjects
- *
ANKLEBONE , *ANEURYSMAL bone cyst , *COMPUTED tomography , *TREATMENT effectiveness , *RETROSPECTIVE studies , *DOXYCYCLINE , *MAGNETIC resonance imaging , *VERTEBRAE , *DESCRIPTIVE statistics , *SCLEROTHERAPY , *ORTHOPEDICS , *SCAPULA , *ALBUMINS , *SENSITIVITY & specificity (Statistics) ,RESEARCH evaluation - Abstract
Background A widely accepted set of imaging criteria or classification has not yet been adopted to evaluate response to treatment by percutaneous sclerotherapy for aneurysmal bone cyst (ABC). In this article, we described and illustrated the Royal Orthopaedic Hospital (ROH) scoring system which is a new, reproducible, and objective tool to evaluate the radiological response. We also reported our institutional experience in the efficacy of computed tomography (CT)-guided sclerotherapy for treating such lesions. Patients and Methods A retrospective analysis was conducted for 19 patients who underwent CT-guided sclerotherapy with doxycycline and albumin to treat ABC. Follow-up magnetic resonance imaging, at a minimum of 12 months, was assessed according to the four ROH scoring system parameters: cystic component, fluid–fluid level, presence of consolidation, and cortical integrity. The cumulative score was used to grade response as either: excellent, good, equivocal, or poor. Results Out of 19 patients with a mean age of 17.8 years, 11 cases occurred in the long bones, 5 cases in the pelvis, and 1 in each of the C3 vertebral body, scapula, and talus. The mean parameter of response score for cystic component was 2, fluid–fluid level was 1.3, consolidation was 2, and cortical integrity was 2.1. Four cases showed excellent response, 12 cases showed good response, 2 cases showed equivocal response, and 1 case showed poor response. Interrater reliability was excellent (κ = 0.9). Conclusion The ROH scoring system provides the radiologist and surgeon with an objective method to score imaging parameters of response independently and achieve a grade based on the cumulative score. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Low temperature offers better foam stability.
- Author
-
Serkan, Mola and Gokay, Deniz
- Abstract
Background Methods Results Conclusion The foam's structural longevity, linked to the effectiveness of sclerotherapy, depends on preparation conditions. The factors enhancing the treatment's effectiveness and efficacy are still under discussion.We conducted an in vitro preclinical research, which included 144 independent trials. A total of 8 combinations involving 18 trials were designed according to settings of +4°C and room temperature (20–22°C), liquid‐to‐air ratios of 1/1 and 1/4, and polidocanol concentrations of 0.5% and 1% using the modified Tessari method. Our study aimed to examine the effect of air ratio, agent temperature, and polidocanol concentration on stability by assessing the foam half‐time (FHT) and defining the optimal preparation conditions.The mean FHT was 117 ± 30.4 s. The longest FHT was in a 1:4 air‐to‐sclerosant ratio at +4°C, regardless of the sclerosant concentration (for %0.5 mean FHT: 146.2 ± 13.9 s, for % 1 mean FHT: 146.9 ± 18 s). There was a significant interaction among the three variables on FHT (p = 0.001). Temperature emerged as the primary factor (F(1, 136) = 124, p < 0.001, ηp2 = 0.477), with lower temperatures markedly enhancing the longevity (p < 0.001). Preparation at a temperature of 4°C resulted in an extended FHT of 32.5 s compared to 22°C (95% CI: 24.06–41.04 s).The temperature, agent concentration, and gas ratio significantly influence the stability of the physician‐compounded foam. The low temperature at +4°C may offer better FHT for sclerotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Is salvage Plug-Assisted Retrograde Transvenous Obliteration (PARTO) safe and effective for bleeding gastric varices ?- A preliminary single-center experience.
- Author
-
Patel, Ranjan Kumar, Tripathy, Taraprasad, Panigrahi, Manas Kumar, Nayak, Hemant Kumar, Samal, Subash Chandra, Pattnaik, Bramhadatta, Dutta, Tanmay, Gupta, Sunita, Mohakud, Sudipta, Naik, Suprava, and Deep, Nerbadyeswari
- Subjects
- *
GASTRIC varices , *SCLEROTHERAPY , *ESOPHAGEAL varices , *DERIVATIVES (Mathematics) , *PATIENT selection , *HEMORRHAGE - Abstract
Background: Vascular plug-assisted retrograde transvenous obliteration (PARTO) obliterates the gastric varices and portosystemic shunt, thus resulting in a lower rebleeding rate than endoscopic glue/sclerotherapy. Aims: To evaluate the safety and efficacy of PARTO as salvage therapy in liver cirrhosis with gastric variceal bleed (GVB) after failed endotherapy. We assessed the clinical success rate and changes in liver function at 6- months. Materials and methods: Patients who underwent salvage PARTO after failed endotherapy for GVB (between December 2021 and November 2022) were searched and analyzed from the hospital database. Clinical success rate and rebleed rate were obtained at six months. Child–Pugh score (CTP) and Model for end-stage liver disease (MELD) score were calculated and compared between baseline and 6-month follow-up. Results: Fourteen patients (n = 14, Child–Pugh class A/B) underwent salvage PARTO. Nine had GOV-2, and five had IGV-1 varices. The mean shunt diameter was 11.6 ± 1.6 mm. The clinical success rate of PARTO was 100% (no recurrent gastric variceal hemorrhage within six months). No significant deterioration in CTP (6.79 ± 0.98 vs. 6.21 ± 1.52; p = 0.12) and MELD scores (11.5 ± 4.05 vs. 10.21 ± 3.19; p = 0.36) was noted at 6 months. All patients were alive at 6 months. One patient (n = 1, 7.1%) bled from esophageal varices after three days of PARTO and was managed with variceal banding. 21.4% (3/14) patients had progression of esophageal varices at 6 months requiring prophylactic band ligation. Three patients (21.4%) had new onset or worsening ascites and responded to low-dose diuretics therapy. Conclusions: PARTO is a safe and effective procedure for bleeding gastric varices without any deterioration in liver function even after six months. Patient selection is critical to prevent complications. Further prospective studies with larger sample size are required to validate our findings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. The Effect of Pushing Rate on Foam Stability in the Tessari Method.
- Author
-
Azmoun, Sajjad, Yiran Liu, Kai Bian, Anwei Chen, and Shaohua Liu
- Subjects
- *
FOAM , *SCLEROTHERAPY , *TIME management - Abstract
BACKGROUND The Tessari method is commonly used in sclerotherapy for producing foam, involving 2 syringes pushed back and forth 20 times with the use of a 3-way connector. Many factors affect the foam stability which is crucial for clinical efficacy. OBJECTIVE This study aimed to identify the optimal pushing rate which may impact the foam stability. MATERIALS AND METHODS Polidocanol (POL) solution (1% and 3%) was used to make sclerosant foam via the Tessari method, with a total of 20 pushes performed at different time durations: 10, 15, 20, 25, 30, 35, and 40 seconds. The foam stability was recorded using foam half-life time (FHT), and the pushing pressure to the syringe was recorded using a selfmade electric device. Both FHT and the pressure among different groups were compared respectively. RESULTS The FHT was decreased as pushing duration exceeding 20 seconds in POL 1% and 15 seconds in POL 3%. Both the highest FHT and pressure point were located in the 10-second group. CONCLUSION It is recommended to complete 20 back-and-forth passages within 10 seconds to create stable foam. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. A Brief Review of Varicose Veins in the Upper Limb from an Ayurvedic Perspective.
- Author
-
BOBADE, SHUBHAM, ASUTKAR, SHEETAL, and KADAV, AMAR
- Subjects
- *
VARICOSE veins , *SUBCLAVIAN veins , *ARTERIOVENOUS fistula , *SODIUM sulfate , *CONGENITAL disorders , *TORTUOSITY - Abstract
Varicose veins typically occur in the lower limbs, caused by valvular insufficiency leading to the swelling and tortuosity of subcutaneous veins. Although rare in the upper limbs, they can be successfully diagnosed and treated. Rare causes include congenital vascular anomalies like Klippel-Trenaunay syndrome and Parkes Weber syndrome, characterised by Arteriovenous (AV) fistulae. Subclavian vein thrombosis-induced venous outflow obstruction is another uncommon cause. Diagnosis involves a thorough history taking with clinical examination, often supplemented by investigations. Invasive procedures are rarely necessary but may be used in unique cases to define the pathology further. Treatment for upper limb varicose veins closely mirrors lower limb approaches. The stab-avulsion technique combined with stripping of lengthier sections yields outstanding cosmetic and functional results. Surgical ligation with stripping effectively eliminates varicosities with a low risk of recurrence. Sclerosing agents like Sodium Tetradecyl Sulphate and Polidocanol are substitutes for surgery. In cases of varicosities resulting from upper limb arteriovenous fistulae, surgical intervention involving ligation of the distal venous limb or division of the fistula is the standard approach. In summary, while upper limb varicose veins are exceptionally rare, they can be accurately diagnosed and effectively treated with surgical interventions similar to lower limb varicose veins. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Pathophysiology and Clinical Implications of Ovarian Endometriomas.
- Author
-
Nezhat, Farr R., Cathcart, Ann M., Nezhat, Ceana H., and Nezhat, Camran R.
- Subjects
- *
SCLEROTHERAPY , *PATHOLOGICAL physiology , *PHENOTYPIC plasticity , *LAPAROSCOPIC surgery , *CYSTECTOMY , *FERTILITY - Abstract
Ovarian endometriomas affect many patients with endometriosis and have significant effects on quality of life, fertility, and risk of malignancy. Endometriomas range from small (1–3 cm), densely fibrotic cysts to large (20 cm or greater) cysts with varying degrees of fibrosis. Endometriomas are hypothesized to form from endometriotic invasion or metaplasia of functional cysts or alternatively from ovarian surface endometriosis that bleeds into the ovarian cortex. Different mechanisms of endometrioma formation may help explain the phenotypic variability observed among endometriomas. Laparoscopic surgery is the preferred first-line modality of diagnosis and treatment of endometriomas. Ovarian cystectomy is preferred over cyst ablation or sclerotherapy for enabling pathologic diagnosis, improving symptoms, preventing recurrence, and optimizing fertility outcomes. Cystectomy for small, densely adherent endometriomas is made challenging by dense fibrosis of the cyst capsule obliterating the plane with normal ovarian cortex, whereas cystectomy for large endometriomas can carry unique challenges as a result of adhesions between the cyst and pelvic structures. Preoperative and postoperative hormonal suppression can improve operative outcomes and decrease the risk of endometrioma recurrence. Whether the optimal management, fertility consequences, and malignant potential of endometriomas vary on the basis of size and phenotype remains to be fully explored. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Vertebral hemangiomas: a review on diagnosis and management.
- Author
-
Kato, Kyle, Teferi, Nahom, Challa, Meron, Eschbacher, Kathryn, and Yamaguchi, Satoshi
- Subjects
- *
SPINE radiography , *SPINAL cord diseases , *HEMANGIOMAS , *VERTEBROPLASTY , *DIFFERENTIAL diagnosis , *COMPUTED tomography , *SPINAL tumors , *LAMINECTOMY , *SPINAL cord compression , *MAGNETIC resonance imaging , *SCLEROTHERAPY , *RADICULOPATHY , *LUMBAR vertebrae , *SPINAL fusion , *SPINE , *BACKACHE - Abstract
Background: Vertebral hemangiomas (VHs) are the most common benign tumors of the spinal column and are often encountered incidentally during routine spinal imaging. Methods: A retrospective review of the inpatient and outpatient hospital records at our institution was performed for the diagnosis of VHs from January 2005 to September 2023. Search filters included "vertebral hemangioma," "back pain," "weakness," "radiculopathy," and "focal neurological deficits." Radiographic evaluation of these patients included plain X-rays, CT, and MRI. Following confirmation of a diagnosis of VH, these images were used to generate the figures used in this manuscript. Moreover, an extensive literature search was conducted using PubMed for the literature review portion of the manuscript. Result: VHs are benign vascular proliferations that cause remodeling of bony trabeculae in the vertebral body of the spinal column. Horizontal trabeculae deteriorate leading to thickening of vertical trabeculae which causes a striated appearance on sagittal magnetic resonance imaging (MRI) and computed tomography (CT), "Corduroy sign," and a punctuated appearance on axial imaging, "Polka dot sign." These findings are seen in "typical vertebral hemangiomas" due to a low vascular-to-fat ratio of the lesion. Contrarily, atypical vertebral hemangiomas may or may not demonstrate the "Corduroy" or "Polka-dot" signs due to lower amounts of fat and a higher vascular component. Atypical vertebral hemangiomas often mimic other neoplastic pathologies, making diagnosis challenging. Although most VHs are asymptomatic, aggressive vertebral hemangiomas can present with neurologic sequelae such as myelopathy and radiculopathy due to nerve root and/or spinal cord compression. Asymptomatic vertebral hemangiomas do not require therapy, and there are many treatment options for vertebral hemangiomas causing pain, radiculopathy, and/or myelopathy. Surgery (corpectomy, laminectomy), percutaneous techniques (vertebroplasty, sclerotherapy, embolization), and radiotherapy can be used in combination or isolation as appropriate. Specific treatment options depend on the lesion's size/location and the extent of neural element compression. There is no consensus on the optimal treatment plan for symptomatic vertebral hemangioma patients, although management algorithms have been proposed. Conclusion: While typical vertebral hemangioma diagnosis is relatively straightforward, the differential diagnosis is broad for atypical and aggressive lesions. There is an ongoing debate as to the best approach for managing symptomatic cases, however, surgical resection is often considered first line treatment for patients with neurologic deficit. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Middle third falcine meningiomas-surgical nuances for cortical venous preservation.
- Author
-
Bansal, Chirag, Shah, Het, Bora, Santanu Kumar, and Suri, Ashish
- Subjects
- *
FIBRIN tissue adhesive , *CRANIOPHARYNGIOMA , *SCLEROTHERAPY , *VEINS , *MENINGIOMA , *INFARCTION - Abstract
Purpose: To improve postoperative outcome in middle third falcine meningiomas by cortical venous preservation. Background: Falcine meningiomas arise from the falx and do not involve the superior sagittal sinus (SSS). Their complete resection is often associated with the risk of venous infarction in the eloquent cortex due to overlying superficial cortical veins on the tumors. Method: We report one case of middle third falcine meningioma, where we used the posterior interhemispheric corridor for tumor approach. Conclusion: Use of the posterior interhemispheric approach, carefully raised bone flap, along with sharp dissection and vein reinforcement using fibrin glue can help to preserve the cortical veins while resecting the falcine meningiomas. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Laser-sclerosing foam hybrid treatment, a non-tumescent technique for insufficient great saphenous vein ablation.
- Author
-
Victoria M, Gerardo E, Rujano A, Adrian J, and Zilipo, Giacomo M
- Subjects
- *
ABLATION techniques , *BURNS & scalds , *RETROSPECTIVE studies , *ULTRASONIC imaging , *LASER therapy , *SCLEROTHERAPY , *LONGITUDINAL method , *VENOUS insufficiency , *SAPHENOUS vein , *THROMBOSIS - Abstract
Objective: We aim to report on the Laser-Sclerosing Foam Hybrid Treatment (LSFHT) and its outcomes when used on patients with great saphenous vein (GSV) insufficiency. Methods: This was a single center retrospective cohort study on patients with GSV insufficiency that were treated with the LSFHT technique, a surgical procedure that comprises the use of both sclerosing foam and endovenous ablation and avoids the use of tumescent anesthesia. Occlusion rates and complications were reported. Results: 139 legs from 106 patients were operated, achieving a 100% occlusion rate, while only a small burn and 2 popliteal vein thrombosis cases occurred. Conclusion: The study suggests that the LSFHT is a feasible fast procedure that proved both effective and safe for the treatment of GSV insufficiency. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Microsclerotherapy.
- Author
-
Tan, Matthew, Shaydakov, Evgeny, Parsi, Kurosh, and Davies, Alun H
- Subjects
- *
MEDICAL protocols , *CARDIOVASCULAR diseases , *DUPLEX ultrasonography , *DECISION making , *TREATMENT effectiveness , *SCLEROTHERAPY , *VENOUS insufficiency , *PATIENT satisfaction , *TELANGIECTASIA , *HYPERPIGMENTATION - Abstract
The article focuses on microsclerotherapy as a treatment for chronic venous disease, particularly addressing technical considerations and management recommendations. Topics discussed include the necessity of duplex ultrasound assessment for symptomatic patients, the use of liquid and foam sclerosants, and post-procedural compression to improve outcomes and reduce complications.
- Published
- 2024
- Full Text
- View/download PDF
12. Varikosis – aktuelle Therapiekonzepte.
- Author
-
Lisii, C. and Heckenkamp, J.
- Abstract
Varicosis is a chronic progressive disease characterized by varicose veins of the lower extremities. Pain, swelling and heaviness of the legs are typical symptoms. These symptoms are caused by a pathological venous reflux, arising from a weakness of the vein wall and progressive venous insufficiency. The indications for invasive surgery are the symptomatic clinical, etiological, anatomical, pathophysiological (CEAP) stages C2s–C6. Compression therapy and venoactive drugs can be recommended for conservative therapy. When it comes to surgical treatment conventional open vein surgery is associated with the best long-term results. Endovenous thermal ablation is associated with few postoperative complications and favors earlier mobilization of the patient. Sclerotherapy has become established with good clinical results for the ablation of reticular and telangiectatic veins, for recurrences and complicated vein anatomy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Effect of catheter-directed ethanol sclerotherapy on ovarian reserve in patients with recurrent endometrioma: comparative analysis with primary endometriosis.
- Author
-
Lee, Jae Kyung, Han, Kichang, Choi, Euna, Baek, Jinkyung, Kim, Hae-Rim, Kim, Man-Deuk, Kim, Heeyon, and Seo, Seok Kyo
- Subjects
- *
SCLEROTHERAPY , *OVARIAN reserve , *ENDOMETRIOSIS , *OVARIES , *ANTI-Mullerian hormone , *ELECTRONIC health records - Abstract
Objective: Catheter-directed ethanol sclerotherapy (CDS) is known to less affect the ovarian function, with comparable efficacy. This study aims to investigate the change in ovarian reserve after catheter-directed ethanol sclerotherapy in patients with recurrent endometrioma, as compared to primary endometrioma. Materials and methods: Retrospective, observational study. Electronic medical records and images of patients with endometrioma who underwent CDS from August 2014 to April 2022 at a single institution were obtained. Patients aged > 18 years old and with anti-Müllerian hormone (AMH) level between 0.8 and 10.0 with regular menstruation were enrolled. Cyst diameter, laterality, AMH level, and CA-125 level before and after 1 month, 6 months, 1 year, 2 years, and 3 years of sclerotherapy were obtained. Results: A total of 180 patients were fit for analysis. There was no statistical difference in age and cyst size between the two groups. Mean values of AMH in each group were 3.35 in the primary group and 3.00 in the recurrent group prior to the procedure (p = 0.347). There was no significant difference in delta value of AMH after sclerotherapy in both groups at each follow-up period. Also, this result was consistent when stratified by laterality, preprocedural AMH level, and initial size of endometrioma. No case of recurrence was reported in both groups. Conclusions: The effect of CDS on ovarian reserve is not inferior in recurrent endometrioma compared to primary endometrioma. Since sclerotherapy is known to less deteriorate the ovarian function than surgical removal of endometrioma, clinician could consider this as the first-line therapy in patients with recurrent endometrioma. Clinical relevance statement: Catheter-directed ethanol sclerotherapy for patients with recurrent endometrioma has similar effect on ovarian reserve compared to patients with primary endometrioma. Key Points: • Secondary surgery for endometrioma has significant deleterious effect on ovarian function. • Catheter-directed sclerotherapy (CDS) for endometrioma had equally minimal adverse effect on ovarian reserve, represented as anti-Müllerian hormone (AMH), in both primary and recurrent groups. • Physicians should consider CDS for patients with recurrent endometrioma who desire to preserve ovarian function. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Combination of Minimally Invasive Methods for the Treatment of Varicose Veins.
- Author
-
Ren, Hongcheng, Wang, Bin, Shao, Changgang, Chi, Guoqing, Liu, Rui, Jiang, Yan, Wang, Yufeng, Ding, Mingchao, and Wang, Huaming
- Subjects
- *
PATIENT safety , *ABLATION techniques , *LEG , *RESEARCH funding , *QUESTIONNAIRES , *VARICOSE veins , *MINIMALLY invasive procedures , *TREATMENT effectiveness , *RADIO frequency therapy , *ULTRASONIC imaging , *LIGATURE (Surgery) , *DESCRIPTIVE statistics , *SCLEROTHERAPY , *SURGICAL complications , *COMBINED modality therapy , *QUALITY of life , *SAPHENOUS vein , *CATHETER ablation , *THROMBOSIS , *RIVAROXABAN , *EVALUATION - Abstract
Objective: The aim of the study was to evaluate the efficacy and safety of the combination of minimally invasive methods for the treatment of incompetent great saphenous vein and perforating veins. Methods: Between December 2019 and October 2020, F-care radiofrequency ablation combined with ultrasound-guided foam sclerotherapy and residual perforator ligation and concomitant microphlebectomy were adopted for all eligible patients. The clinical symptoms scores, complications, and quality of life were recorded. Results: 49 patients (64 limbs) with a mean age of 63.29 ± 10.14 years, and 60.9% 4 were male. The 1-year truncal closure rate was 63/64 (98.4%). 1 A significant improvement in the Venous Disability Score, the Venous Segmental Disease Score, the Venous Clinical Severity Score and Chronic Venous Disease Quality of Life Questionnaire Score, at 12 months after the combination of minimally invasive treatment, were observed in the study. One patient developed intermuscular vein thrombosis that was successfully managed with rivaroxaban. Conclusions: The combination of minimally invasive methods is a safe and effective method for the treatment of lower extremity varicose veins. Further large-scale, prospective, multi-center studies are needed to further verify the findings of this study. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Safety and efficacy of intralesional polidocanol sclerotherapy in the treatment of plantar warts: a pilot study.
- Author
-
Eassa, Bayoumy Ibrahim, Abdel-Hameed, Ahmad Kamel Seddeik, and Ismail, Ahmed Ismail Ali
- Subjects
- *
WARTS , *SCLEROTHERAPY , *DYE lasers , *SAPHENOUS vein , *PILOT projects - Abstract
Plantar warts are common skin lesions that continue to represent a therapeutic challenge. They are still resistant to therapy and are highly recurrent, despite the diverse number of treatments available. Therapies targeting vasculature, such as pulsed dye laser, have been used successfully in the treatment of plantar warts. Polidocanol, a detergent sclerosant approved for the sclerotherapy of incompetent and dilated saphenous veins, has also been used as an off-label therapy for a wide range of skin conditions with vascular components such as hemangiomas and pyogenic granuloma. The current, open-label, prospective, pilot study aimed to evaluate the safety and efficacy of the intralesional polidocanol 3% in the treatment of plantar warts. Twenty patients (11 females and 9 males), with plantar warts, aged 12–50 years received biweekly sessions of intralesional polidocanol 3% until complete clearance or for a maximum of 6 sessions. Response to treatment was graded as complete (100% clearance), partial (50–99%), and no response (< 50%). At the end of the study, 12 (60%) patients achieved complete clearance of their warts after 1–5 sessions, 5 (25%) patients had only partial response, and 3 (15%) patients did not achieve any clearance of their warts. The procedure was largely tolerable by patients. Pain at the injection site and bruises were reported by 9 (45%) and 2 (10%) patients, respectively. Both side effects resolved spontaneously and completely within a few days. The findings of the current study suggest that intralesional injection of 3% polidocanol in biweekly sessions may be a safe, effective, and tolerable method for the treatment of plantar warts. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. The Value of Follow-Up Liver Stiffness Changes Measured by Virtual Touch Quantification Elastography for Predicting Recurrence of Gastroesophageal Varices after Endoscopic Injection Sclerotherapy on Cirrhotic Patients.
- Author
-
Duan, Yayang, Zhang, Jinfei, Fan, Min, Kong, Derun, and Zhang, Chaoxue
- Subjects
- *
ESOPHAGEAL varices , *CIRRHOSIS of the liver , *ENDOSCOPIC surgery , *DESCRIPTIVE statistics , *SCLEROTHERAPY , *INJECTIONS , *GASTROSCOPY , *LIVER , *PUBLIC health , *CONFIDENCE intervals , *MEDICAL care costs , *ENDOSCOPY - Abstract
Background and Aims. Recurrence of gastroesophageal varices (GEVs) after sclerotherapy is a public health problem. However, mass screening of recurrence of GEVs through gastroscopy is a high-cost procedure. We aim to evaluate the changes in liver stiffness (LS) over time after endoscopic injection sclerotherapy (EIS) and determine its value in predicting the recurrence of GEVs. Methods. One hundred and thirty-five patients with GEVs who underwent EIS treatment were included in this study. The patients were divided into two groups, namely, the nonrecurrence and recurrence groups, based on endoscopic findings at 6 months after discharge. LS measurements were obtained on five occasions. Repeated measure analysis of variance was employed to assess LS differences at different time points and compare them between the two groups. Results. The LS values during the 6-month postdischarge period were consistently higher than the baseline value (measured on the day of hospitalization). The recurrence group demonstrated sustained elevated LS levels throughout the 6-month follow-up period, while the nonrecurrence group showed a gradual decline in LS. The difference in LS trend between the two groups was statistically significant (P = 0.04). The area under the curve (AUC) values for LS differences were 0.806, with a corresponding 95% confidence interval (CI) of 0.640-0.918 and a cut-off value of 0.556, indicating their potential utility in predicting GEV recurrence. Conclusions. Longitudinal assessment of LS values in post-EIS patients can provide valuable information for predicting the recurrence of GEVs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Fluoroscopy- and Endoscopy-Guided Transoral Sclerotherapy Using Foamed Polidocanol for Oropharyngolaryngeal Venous Malformations in a Hybrid Operation Room: A Case Series.
- Author
-
Ishikawa, Kosuke, Maeda, Taku, Funayama, Emi, Murao, Naoki, Miura, Takahiro, Sasaki, Yuki, Seo, Dongkyung, Mitamura, Shintaro, Oide, Shunichi, Yamamoto, Yuhei, and Sasaki, Satoru
- Subjects
- *
SCLEROTHERAPY , *SOFT palate , *HUMAN abnormalities , *SLEEP apnea syndromes , *TREATMENT effectiveness - Abstract
Background: Treatment of oropharyngolaryngeal venous malformations (VMs) remains challenging. This study evaluated the effectiveness and safety of fluoroscopy- and endoscopy-guided transoral sclerotherapy for oropharyngolaryngeal VMs in a hybrid operation room (OR). Methods: Patients with oropharyngolaryngeal VMs who underwent transoral sclerotherapy in a hybrid OR were enrolled. Results: Fourteen patients (six females, eight males; median age of 26 years; range, 4–71 years) were analyzed. The symptoms observed were breathing difficulties (n = 3), snoring (n = 2), sleep apnea (n = 1), and swallowing difficulties (n = 1). Lesions were extensive in the face and neck (n = 9) and limited in the oropharyngolarynx (n = 5). A permanent tracheostomy was performed on two patients, while a temporary tracheostomy was performed on five patients. The treated regions were the soft palate (n = 8), pharynx (n = 7), base of the tongue (n = 4), and epiglottis (n = 1). The median number of sclerotherapy sessions was 2.5 (range, 1–9). The median follow-up duration was 81 months (range, 6–141). Treatment outcomes were graded as excellent (n = 2), good (n = 7), or fair (n = 5). The post-treatment complication was bleeding (n = 1), resulting in an urgent tracheostomy. Conclusions: Fluoroscopy- and endoscopy-guided transoral sclerotherapy in a hybrid OR can be effective and safe for oropharyngolaryngeal VMs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Unusual origins of cardiac insufficiency: a case of iliac arteriovenous fistula post-spinal disc surgery.
- Author
-
Chen, Zheng-Ji, Ahmad, Nouman, and Huang, Ling-Jin
- Subjects
- *
HEART failure , *ARTERIOVENOUS fistula , *TRICUSPID valve insufficiency , *VENA cava inferior , *HEART murmurs , *HEART failure patients , *COMPUTED tomography , *SCLEROTHERAPY , *TRICUSPID valve surgery - Abstract
In this case report, we present the unique and intriguing case of a 57-year-old man who experienced exertional palpitations and shortness of breath for 5 years. He was diagnosed with idiopathic heart failure three years ago, leading to diuretic treatment. Physical examination revealed notable left lower extremity swelling, severe varicose veins, and cardiac murmurs. Echocardiography showed significant cardiac enlargement and severe functional mitral and tricuspid valve regurgitation. Computed tomography (CT) imaging uncovered a 10 mm left common iliac arteriovenous fistula, causing abnormal early filling of the inferior vena cava (IVC) and marked IVC dilation. Open surgical repair of the arteriovenous fistula resulted in symptom relief and improved cardiac function. This case underscores the importance of considering unusual causes in heart failure patients and highlights the value of early diagnosis and intervention in complex cardiac-vascular interactions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Atypical Calf Cyst Treated With Doxycycline Sclerotherapy: A Case Report.
- Author
-
Hassid, Brandon V. and Davis, Brian A.
- Subjects
- *
ADRENOCORTICAL hormones , *GLUCOSE , *LEG , *SYNOVIAL fluid , *DOXYCYCLINE , *POPLITEAL cyst , *ULTRASONIC imaging , *RESPIRATORY aspiration , *VITAMIN B12 , *MAGNETIC resonance imaging , *SCLEROTHERAPY , *ORTHOPEDIC surgery , *INJECTIONS , *LIDOCAINE - Abstract
There are many types of cysts in the leg; the most common is a popliteal (Baker's) cyst. This occurs when synovial fluid fills the tissue plane between the medial head of the gastrocnemius and the semimembranosus muscle and is often associated with intraarticular knee pathology. Treatment for various types of cysts includes aspiration with or without fenestration, injections with corticosteroids, dextrose, or various sclerosing agents, and surgical excision. This case describes a 58-yr-old man with a large cyst measuring 14.7 x 2.7 x 3.1 cm in size in the lateral calf, within the lateral gastrocnemius, with atypical size and location for a calf cyst. Computed tomography arthrogram showed intraarticular communication with the knee. The cyst recurred after two aspirations and injections with 25% dextrose/lidocaine. Aspiration and injection with doxycycline resulted in temporary relief followed by recurrence. Complete cyst resolution occurred after final aspiration without injectate. The cyst was likely synovial based on location, intraarticular communication, and fluid analysis. We suspect that complete resolution may have been due to repeated aspiration and injection, essentially performing longitudinal cyst fenestration, with possible contribution from doxycycline injection. Further study of intracyst doxycycline injection with reaspiration after 10 mins for treatment of refractory cysts may be warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. LITERATURE REVIEW AND CASE REPORT OF TWO CLOVES SYNDROME PATIENTS TREATED WITH SCLEROTHERAPY.
- Author
-
Ahmad, Saima, Imran, Ahmed, and Qureshi, Abid Ali
- Subjects
- *
LITERATURE reviews , *SCLEROTHERAPY , *SYNDROMES , *LYMPHATIC abnormalities , *VENA cava superior , *SUPERIOR vena cava syndrome - Abstract
This article is a literature review and case report of two patients with CLOVES syndrome who were treated with sclerotherapy. The first case involved an 18-month-old boy who received sclerotherapy injections for a large venous and lymphatic malformation. After two sessions of sclerotherapy, the lesion completely resolved with no recurrence. The second case was a 1-month-old baby girl who developed respiratory distress and died before receiving sclerotherapy. CLOVES syndrome is a rare overgrowth syndrome characterized by lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal/skeletal deformities. Sclerotherapy with bleomycin has shown promising results in treating the vascular component of CLOVES syndrome. [Extracted from the article]
- Published
- 2024
21. Improvement in chronic pelvic pain, orthostatic intolerance and interstitial cystitis symptoms after treatment of pelvic vein insufficiency.
- Author
-
Smith, Steven J, Sichlau, Michael J, Smith, B Holly, Knight, Dacre RT, Chen, Brenda, and Rowe, Peter C
- Subjects
- *
INTERSTITIAL cystitis , *CHRONIC pain , *EHLERS-Danlos syndrome , *T-test (Statistics) , *ORTHOSTATIC intolerance , *PARAMETERS (Statistics) , *DESCRIPTIVE statistics , *CHI-squared test , *MANN Whitney U Test , *MATHEMATICAL statistics , *VENOUS insufficiency , *PELVIC pain , *CONFIDENCE intervals , *COMORBIDITY , *JOINT instability , *DISEASE complications , *SYMPTOMS - Abstract
Objectives: Comorbidities associated with venous origin chronic pelvic pain (VO-CPP) were evaluated pre and post venous treatment to assess change. Materials and methods: 45 women with VO-CPP were treated with venous stenting and/or embolization. Four surveys assessed symptoms pre- and post-treatment: IPPS (chronic pelvic pain), PUF (interstitial cystitis), OHQ (dysautonomia), and modified ROME III (IBS). Prevalence of joint hypermobility was investigated. Results: Ages were 18–65. Pretreatment, 64% and 49% of women were in the severe range for PUF and OHQ, respectively. 40% and 56% met criteria for IBS and Ehlers-Danlos syndrome/Hypermobility Spectrum Disorder (EDS/HSD), respectively. 17eceived an iliac stent, 5 pelvic embolization, and 23 both. Post-treatment, average scores improved: IPPS (by 55%), PUF (34%), and OHQ (49%). Rome III improved only slightly. Conclusion: Pelvic pain, interstitial cystitis, and dysautonomia were frequently found with VO-CPP and improved after venous treatment. EDS/HSD and IBS were common in these women. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Transoral Robotic Surgery for a Rare Case of Venolymphatic Malformation in Parapharyngeal Space.
- Author
-
Dabas, Surendra K., Menon, Nandini N., Ranjan, Reetesh, Shukla, Himanshu, Gurung, Bikas, Tiwari, Sukirti, Bassan, Bharat Bhushan, Sinha, Ajit, Fernandes, Trishala Bhadauria, Arora, Saurabh, Verma, Ankur, Sharma, Ashwani, Biswas, Shubhashish, Patnaik, Nivedita, Tyagi, Tarun, and Singal, Rishu
- Subjects
- *
SURGICAL robots , *HUMAN abnormalities , *POSITRON emission tomography , *HYPEREMIA , *SOFT palate , *SURGICAL excision , *SCLEROTHERAPY - Abstract
Venous malformations are low flow endothelial malformations with aberrant and ectatic venous channels. They are defects in vascular growth which causes functional and cosmetic impairment. Gradual growth in size of the lesion occurs due to venous congestion or thrombosis. Venous malformations in parapharyngeal space are a rare entity and are difficult to diagnose. Case Report. 13 year old boy presented with a history of hyposmia and progressive difficulty in breathing for a duration of 2.5 years. MRI face and neck with contrast showed a 4.5 × 4.3x3.6 cm lesion in the left parapharyngeal space. CT angiogram of brain and neck demonstrated a heterogeneously enhancing mass in the left parapharyngeal region. PET scan illustrated an ill-defined mass in the left pre styloid parapharyngeal space. Biopsy from the lesion showed features consistent with venolymphatic malformation. Flexible laryngoscopy showed a bulge over the left soft palate region with narrowing of nasopharyngeal lumen. Patient underwent transoral robotic surgery for complete excision of the mass. Post-operative period was uneventful. He has been on follow up for the past 1 year with no evidence of any residual or recurrent disease. Venolymphatic malformation is a rare lesion in the parapharyngeal space which is difficult to diagnose pre operatively. Surgical excision is the preferred modality of treatment for deep seated lesions in the parapharyngeal space. The advent of transoral robotic surgery have reduced the morbidity and improved clearance for such cases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Ethanol endometrioma sclerotherapy: safety through 8 years of experience.
- Author
-
Miquel, L, Liotta, J, Pivano, A, Gnisci, A, Netter, A, Courbiere, B, and Agostini, A
- Subjects
- *
SCLEROTHERAPY , *PELVIC pain , *ENDOMETRIOSIS , *BLOOD alcohol , *SALINE solutions , *ETHANOL , *OVARIAN reserve - Abstract
STUDY QUESTION What are the complications of transvaginal ethanol sclerotherapy for the treatment of endometriomas? SUMMARY ANSWER Sclerotherapy is a reliable, minimally invasive method applicable in outpatient procedures but with specific and potential life-threatening complications that need to be identified and prevented. WHAT IS KNOWN ALREADY There are currently few data on the use of transvaginal ethanol sclerotherapy, and we mainly note septic complications. STUDY DESIGN, SIZE, DURATION A retrospective observational cohort study was carried out. The study was conducted at an academic hospital and included 126 women aged 31.9 ± 5.5 years (mean ± SD), between November 2013 and June 2021. We analyzed a total of 157 ethanol sclerotherapy treatment (EST), treated by 131 EST procedures, in 126 women. PARTICIPANTS/MATERIALS, SETTING, METHODS The study included women with an indication for transvaginal ethanol sclerotherapy. Indications were women with at least one endometrioma over 10 mm, isolated or associated with other endometriosis locations, requiring treatment for pain or infertility before assisted reproductive treatment. We followed a standardized transvaginal ethanol sclerotherapy procedure consisting of an ultrasound-guided transvaginal puncture of one or more endometriomas under general anesthesia. The cyst content was completely removed and flushed with saline solution. Ethanol (96%) was injected at 60% of the initial volume of the endometrioma, remained in the cyst for 10 min and was then completely removed. Ethanol loss was defined as a loss of 5 ml or more than 10% of the initial volume of the injected ethanol. Failure was defined by the contraindication of endometrioma puncture because of interposition of the digestive tract, ethanol loss in the previous endometrioma treated (in case of multiple ESTs), failure to aspirate the endometriotic fluid, contraindication to start ethanol injection owing to saline solution leakage, or contraindication to continue ethanol injection owing to suspicions of ethanol leakage at sonography. Intraoperative complications were defined by ethanol loss, positive blood alcohol level, and ethanol intoxication. Postoperative complications were defined by fever, biological inflammatory syndrome, and ovarian abscess. Complications were classified according to the Clavien and Dindo surgical classification, which is a system for classifying postoperative complications in five grades of increasing severity. MAIN RESULTS AND THE ROLE OF CHANCE We reported a total of 17/157 (10.8%) transvaginal ethanol sclerotherapy failures during 14/131 (10.7%) transvaginal ethanol sclerotherapy procedures in 13/126 (10.3%) women. In the same sets of data, complication was reported for 15/157 (9.5%) transvaginal ethanol sclerotherapy in 13/131 (9.9%) transvaginal ethanol sclerotherapy procedures in 13/126 (10.3%) women. Nine of 126 women (7.1%) had a grade I complication, one (0.8%) had a grade II complication (medical treatment for suspicion of pelvic infection), two (1.6%) had a grade III complication (ovarian abscess) and one (0.8%) had a grade IV complication (ethanol intoxication). We did not observe any grade V complications. LIMITATIONS, REASONS FOR CAUTION This was a retrospective study and pain assessment not considered. The benefit-risk balance of endometrioma transvaginal ethanol sclerotherapy was not evaluated. WIDER IMPLICATIONS OF THE FINDINGS Our study is the first to evaluate the complications of transvaginal ethanol sclerotherapy with such a large cohort of women in a standardized protocol. Transvaginal ethanol sclerotherapy seems to be an effective alternative to laparoscopic surgery in the management of endometriomas and limits the alteration of ovarian reserve. Transvaginal ethanol sclerotherapy is a reliable, minimally invasive method applicable on an outpatient basis. The majority of complications are Clavien–Dindo ≤IV, for which preventative measures, or at least early diagnosis and treatment, can be easily performed. The risk of ethanol intoxication is rare, but it is a life-threatening risk that must be avoided by appropriate implementation and promotion of the sclerotherapy procedures. STUDY FUNDING/COMPETING INTEREST(S) None. TRIAL REGISTRATION NUMBER Aix Marseille University's ethics committee registration number 2021-06-03-01. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Complete and Incomplete Alcohol Sclerotherapy for Treatment of Symptomatic Hepatic Cysts: Comparison of Volume Reduction and Clinical Outcomes.
- Author
-
Kim, Ran, Oh, Jung-Suk, Kim, Su-Ho, and Chun, Ho-Jong
- Subjects
- *
SCLEROTHERAPY , *TREATMENT effectiveness , *CYSTS (Pathology) , *THERAPEUTICS , *HEPATIC echinococcosis , *HEPATIC veno-occlusive disease - Abstract
Background: The purpose of this study was to compare the efficacy of incomplete alcohol sclerotherapy with complete treatment for hepatic cysts. Methods: From 2005 to 2021, a total of 80 patients (19 males, 61 females; median age 65 years; age range, 42–86 years) who underwent alcohol sclerotherapy for symptomatic benign hepatic cysts were enrolled and retrospectively reviewed. Complete treatment was defined as injecting 25–33% of the aspirated cyst volume with alcohol in 2–3 cycles, with a maximum of 100 mL per cycle. The overall volume reduction rate was compared between the complete and incomplete treatment groups. The response, based on cystic volume reduction, was classified as a complete regression (CR), near-complete regression (NCR), partial regression (PR), or no response (NR). CR and NCR were considered objective responses. Among 80 patients with 85 hepatic cysts, 26 patients with 29 hepatic cysts received incomplete treatment. Results: The overall volume reduction rate was not significantly different between the complete and incomplete treatment groups (94.39% vs. 95.47%, respectively, p = 0.623). The CR and NCR groups showed a significantly higher rate of symptom improvement than the PR and NR groups (p = 0.043). Conclusions: In conclusion, the efficacy of incomplete alcohol sclerotherapy was not inferior to that of complete treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Radiofrequency ablation versus stripping of great saphenous vein in the management of varicose veins.
- Author
-
Tyagi, Vikas, Chopra, Saumya, Ahmad, Samir, Jain, Sudhir Kumar, and Dua, Amrita
- Subjects
- *
VARICOSE veins , *SAPHENOUS vein , *CATHETER ablation , *SCLEROTHERAPY , *TERTIARY care , *PATIENT satisfaction - Abstract
Background: Varicose veins are defined as dilated, tortuous subdermal veins >3 mm in diameter. It is a common entity affecting an estimated 10% of population. Aims and Objectives: The aim was to compare the efficacy of radiofrequency ablation (RFA) with great saphenous vein (GSV) stripping in patients with lower limb varicose veins in terms of disappearance of visible varicosities. Materials and Methods: It was a prospective randomized controlled study, conducted in a tertiary care medical college with the study population consisting of patients suffering from varicose veins. Totally 30 patients were enrolled and divided into 2 groups of 15 patients each. Group A underwent RFA while Group B underwent stripping of GSV with flush ligation of saphenofemoral junction. Results: The mean duration of the procedure in Group A was 53.67±6.6 min while in Group B it was 101.4±11.85 min which was statistically significant (P<0.0001). The mean duration of return to routine activities and work was 2.2±0.41 days in Group A and 3.07±1.16 days in Group B which was statistically significant (P=0.024). Post-operative analgesic requirement was similar in both groups (P=0.224). Complete remission was observed in all patients at 12 months visit and there was no recurrence identified even after a follow-up period of 4 years. Conclusion: RFA was found to be as effective as stripping of GSV in terms of obliteration of veins. The duration of procedure was found to be much less in RFA. Furthermore, cosmetic results, ulcer healing and patient satisfaction rate was better in RFA group. Patient return to normal activity was significantly earlier in RFA group. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents.
- Author
-
Gracé, Joseph, Connor, David, Bester, Lourens, Rogan, Christopher, and Parsi, Kurosh
- Subjects
- *
IN vitro studies , *VEGETABLE oils , *CONTRAST media , *SCLEROTHERAPY , *ADHESIVES , *SPECTROPHOTOMETRY - Abstract
Objectives: The objective is to investigate the interaction of sclero-embolic and contrast agents with the polymerisation of medical grade n-butyl-cyanoacrylates. Methods: An in vitro spectrophotometric absorbance method was developed to detect changes in light transmission to measure n-BCA polymerisation. The initiation and the rate-of-polymerisation of mixtures of n-BCA with sclero-embolic and contrast agents were investigated. Results: Initiation of polymerisation: VENABLOCK™ and HISTOACRYL® were the fastest agents to polymerise, while VENASEAL™ was the slowest. Rate of polymerisation: Hypertonic saline inhibited the polymerisation of all n-BCAs, while hypertonic glucose prolonged the polymerisation rate. ETHANOL and detergent sclerosants had no effect. Contrast agents OMNIPAQUE™ and ULTRAVIST® initiated and prolonged the polymerisation of n-BCA, but in contrast, LIPIODOL® failed to initiate the process. Conclusions: The commercially available medical cyanoacrylates differ in their polymerisation rates. These polymerisation rates are further affected when these products are used in conjunction with other compounds, such as sclero-embolic and contrast agents. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Sclerotherapy: Indications and safety volumes.
- Author
-
Tan, Matthew, Moreno, Hernan Bauza, Bechter-Hugl, Beate, Gianesini, Sergio, Connor, David, Parsi, Kurosh, and Davies, Alun H
- Subjects
- *
CHRONIC disease treatment , *VEINS , *ULTRASONIC imaging , *MEDICAL protocols , *SCLEROTHERAPY , *VARICOSE veins , *VASCULAR diseases , *PATIENT safety , *DISEASE management , *THERAPEUTICS - Abstract
The article discusses the indications and safe volumes for sclerotherapy in the treatment of chronic venous disease, emphasizing the need for careful patient selection and tailored treatment approaches. Topics include contraindications for sclerotherapy, diagnostic evaluation using duplex ultrasound, and recommendations for sclerosant type and concentration based on target vessel characteristics.
- Published
- 2024
- Full Text
- View/download PDF
28. Outcomes and Recurrence Rate of Esophageal Varices after Endoscopic Treatment in Patients with Alcoholic Cirrhosis and Viral Cirrhosis.
- Author
-
Yoshihiro Furuichi, Ryohei Nishiguchi, Takeshi Shimakawa, Tomoyuki Fujiwara, Koichiro Sato, and Hiroyuki Kato
- Abstract
The article investigates and compares the outcomes and recurrence rates of esophageal varices following endoscopic treatment in patients with alcoholic liver cirrhosis and hepatic B/C virus-related liver cirrhosis. It explores differences in overall survival and variceal recurrence rates between these patient groups, shedding light on the effectiveness of endoscopic injection sclerotherapy in managing variceal complications in these distinct cirrhotic populations.
- Published
- 2024
- Full Text
- View/download PDF
29. Arteriovenous malformations as a presenting sign of PTEN hamartoma tumor syndrome: A case series.
- Author
-
Dykman, Morgan, Pillai, Nishitha R., Lenhart, Kelsey, Nicholson, Cynthia, Boull, Christina, Fritz, Erin, Flanagan, Siobhan, and Maguiness, Sheilagh
- Subjects
- *
HEREDITARY hemorrhagic telangiectasia , *ARTERIOVENOUS malformation , *PTEN protein , *HAMARTOMA , *DELAYED diagnosis , *SYNDROMES - Abstract
High‐flow vascular malformations have been associated with multiple syndromes including capillary malformation–arteriovenous malformation (CM–AVM) syndrome, hereditary hemorrhagic telangiectasia syndrome, and less commonly, phosphatase and tensin homolog hamartoma tumor syndrome (PHTS). We present a series of three patients with clinically challenging complex AVMs who were found to have underlying PHTS. In all patients, diagnosis was delayed, and the presence of the AVM prompted sampling and genetic testing for PHTS in the absence of other clinical features of the condition. This series highlights the importance of screening for PHTS in the setting of high‐flow vascular malformations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Modified sclerotherapy needle catheter as protective sheath for laser fibre passage in channelled flexible laryngoscopes.
- Author
-
Sabotin, Ryan P., Hoffman, Matthew R., Van Daele, Douglas J., Stegall, Helen, and Hoffman, Henry T.
- Subjects
- *
SCLEROTHERAPY , *CARBON dioxide lasers , *LARYNGOSCOPES , *LASERS , *CATHETERS , *FIBERS , *NEEDLES & pins - Abstract
This article discusses the use of a modified sclerotherapy needle catheter as a protective sheath for laser fiber passage in channelled flexible laryngoscopes. The authors found that the sharp tip of the laser fiber can cause damage to the working channel of the laryngoscope, leading to costly repairs. They propose using a 25-gauge sclerotherapy needle catheter as a sheath to protect the working channel during laser fiber insertion. The study found that this method was effective in preventing damage to the laryngoscope and resulted in no reported repairs. The authors suggest that this inexpensive alternative could be used to protect the working channel during ablative laryngeal procedures. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
31. Sclerotherapy of the Post renal Transplant Lymphoceles: A Meta-Analysis.
- Author
-
des Bordes, Ursula, Hoang, Timothy, Dale, Benjamin S., and Sharma, Ashwani Kumar
- Subjects
- *
SCLEROTHERAPY , *KIDNEY transplantation , *LYMPHOCELE , *KRUSKAL-Wallis Test - Abstract
This study evaluated the effectiveness of sclerotherapy in treating lymphoceles after kidney transplantation, focusing on factors such as recurrence rates and procedural success. Retrospective studies using sclerotherapy as the only form of treatment for postrenal transplant lymphoceles were included. All studies used percutaneous transcatheter sclerotherapy as treatment, and the success rate of the intervention was recorded. Sixty-one references were obtained by manually searching the MEDLINE (n = 20), Embase (n = 41), and Cochrane Library databases (n = 0) for retrospective research studies that included the keywords "sclerotherapy post renal transplant lymphoceles." After removing 3 duplicates, 50 of the remaining articles were excluded after the screening, and the remaining studies were extracted for demographic data and our primary outcome of the success rate of sclerotherapy. A descriptive analysis of the outcomes and complication rates associated with sclerotherapy interventions for lymphoceles is provided. A high degree of variation across the different studies was observed. According to the Kruskal–Wallis test, there was no correlation between the sclerosant used and the sclerotherapy complication rate (P =.472) or the success rate (P =.591). There was also no correlation between the gender of the patient and the success rate; however, there was a significant difference in the complication rate by gender (P <.005). In conclusion, different sclerosant products have been used for therapy with no consensus on the most efficacious product because the success rate has been variable. In addition, the gender of the patient may influence the complication rates associated with sclerotherapy for lymphoceles in patients post–kidney transplant. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Endovenous laser ablation (EVLA) for vein insufficiency: two-year results of a multicenter experience with 1940-nm laser diode and a novel optical fiber.
- Author
-
Palombi, Luca, Morelli, Monica, Bruzzese, Dario, Martinelli, Fabio, Quarto, Gennaro, and Bianchi, Pier Giovanni
- Subjects
- *
LASER ablation , *SEMICONDUCTOR lasers , *OPTICAL fibers , *VARICOSE veins , *TECHNOLOGICAL innovations , *SCLEROTHERAPY , *TREATMENT effectiveness - Abstract
Thermoablative techniques currently represent, in accordance with international guidelines, the most used methods in the treatment of varicose veins. From some years, lasers with a wavelength greater than 1900 nm have been introduced for EndoVenous Laser Ablation (EVLA) treatment. However, currently, few clinical studies regarding this new technology are reported in the medical literature. The aim of this study is to evaluate outcomes at a 2-year follow-up (mid-term) of EVLA of varicose veins of the lower limbs using a 1940-nm laser and a new cylindric monoring fiber. This clinical trial was conducted as a multicenter, retrospective, non-randomized, non-blind clinical study. Ninety-three patients were enrolled for a total of one hundred consecutive procedures performed in the period between January 2021 and May 2021 in two Italian facilities. The primary efficacy endpoint was the occlusion rate of the treated vein immediately after surgery and at the follow-up (24 months). The secondary efficacy endpoint was the evaluation of the parameters of energy delivered during the procedure (power and linear energy density or LEED). The primary safety endpoints were the incidence of pain (1 day and 7 days after surgery) and the rate of intraoperative and postoperative complications. The precepted pain was evaluated with the visual analog scale (VAS). The secondary safety endpoint was the evaluation of the improvement of the patient's symptoms related to venous disease. This evaluation was conducted by recording the changes in clinical, etiologic, anatomic, and pathophysiologic (CEAP) classification. All procedures were carried out regularly on an outpatient basis, and no intraoperative complications occurred. The occlusion rate of the target veins was 100% at 7- and 30-day controls. At follow-up controls, performed at 6 months, 1 and 2 years carried out showed an occlusion rate respectively of 99% (97 to 100), 96.9% (93.6 to 100), and 95.9% (92.1 to 99.9). The secondary efficacy endpoint was the evaluation of the parameters of energy delivered during the procedure (power watt and linear energy density): As regards the power parameters, we report an average of watts of 4.5 ± 0.8 [2.5 to 6] and linear energy density delivered (LEED) of 41.2 ± 8.6 [(21.1 to 66.7)]. The pain reported (with VAS scale) on 1 day of the procedure was 2 [1; 3] and 1 [0 to 4] at 7 days. All patients showed improved symptoms related to venous disease, with reduction of the individual CEAP class to which they belong. This study demonstrates that EndoVascular Laser Ablation (EVLA) treatment of varicose veins with a wavelength > 1900 nm is safe and effective. The overall occlusion rate was high. The reported results suggest that using lower parameters, such as output power (watts) and LEED (linear energy density), do not reduce the success rate of the treatment when used over 35 J/cm. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Long-Term Clinical and Imaging Findings in Patients with Lower Extremity Varicose Veins Treated with Endovenous Laser Treatment: A Follow-Up Study of up to 12 Years.
- Author
-
Ghanaati, Hossein, Jalali, Amir Hossein, Shakiba, Madjid, Zarei, Diana, Ghavami, Nafiseh, and Firouznia, Kavous
- Subjects
- *
DIAGNOSTIC imaging , *SAPHENOUS vein , *VENOUS insufficiency , *SCLEROTHERAPY , *LASERS , *VARICOSE veins , *DISEASE relapse - Abstract
Introduction. This study investigates the long-term effectiveness and safety of endovenous laser treatment (EVLT) for chronic venous insufficiency (CVI), a condition commonly caused by dysfunctional valves in the venous circulation system. Materials and Methods. In this retrospective cohort study, patients underwent EVLT and were followed up for successive short intervals and one last time after a median duration of 9-year postprocedural. Pre- and postprocedure duplex ultrasound was used to assess changes in the great saphenous vein (GSV) diameter, reflux, and saphenofemoral junction incompetence. Quality of life was evaluated using the SF-36 and Aberdeen Varicose Vein Questionnaire (AVVQ). Results. Sixty-eight patients with a mean age of 52.4 ± 12.4 years were enrolled in the study. The mean follow-up time was 8.9 ± 2.1 years, ranging from 5 to 12 years. The mean GSV diameter significantly decreased in all patients (whole group) across proximal (from 5.8 ± 2.3 mm to 4.2 ± 2.1 mm), middle (from 4.7 ± 1.6 mm to 2.8 ± 2.2 mm), and distal (from 4.5 ± 2.3 mm to 2.2 ± 2.2 mm) segments, with P < 0.001. A disease recurrence rate of 33.8% was noted, predominantly in male patients and those with larger middle GSV diameters (OR = 5.2 (95 % CI = 1.3 -20.4) and OR = 1.5 (95 % CI = 1 -2.1), respectively). The average follow-up time for patients without recurrence was 8.8 ± 2.1 years. Almost half of the patients without recurrence were followed up for 10 years or more (49%). Conclusion. The efficacy of EVLT in managing varicose veins is demonstrated by its relatively low recurrence rate over a 10-year follow-up period, highlighting EVLT as a viable long-term treatment strategy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Minimally Invasive Treatment of Chyle Leak After Thyroidectomy and Cervical Lymph Node Dissection in Patients with Thyroid Carcinoma: Results of a Study Involving 36 Patients.
- Author
-
Cuong, Nguyen Ngoc, Hoan, Le, My, Thieu Thi Tra, Luu, Doan Tien, Linh, Le Tuan, Canh, Pham Hong, Tinh, Trieu Quoc, Chi, Tran Nguyen Khanh, Trung, Nguyen Quang, and Hoa, Tran Quoc
- Subjects
- *
LYMPHADENECTOMY , *DISSECTION , *THYROIDECTOMY , *THYROID cancer , *THORACIC duct , *TREATMENT effectiveness , *COMPUTED tomography - Abstract
Chyle leak (CL) after head and neck surgery is a rare but well-known complication. In patients with high-output leakage, the treatment can be complicated. This study aims to report on a recent innovation in lymphatic intervention for treating such patients. Materials and Methods: A retrospective review of 36 patients with chyle leak after neck surgery for thyroid cancer was conducted to assess the efficacy of percutaneous lymphatic embolization and thoracic duct (TD) disruption. Results: Antegrade catheterization of the thoracic duct was achieved in 31 of 36 patients (86.1%). Therefore, embolization of the thoracic duct and thoracic duct branches was performed in 26 and 5 patients, respectively. In 5 cases of unsuccessful antegrade catheterization into the thoracic duct, transcervical access embolization was performed in 2 patients, and TD disruption (TDD) was performed in 3 patients. The pooled overall technical success rate of lymphatic embolization was 33/36 patients (91.7%). One patient who underwent thoracic duct embolization (TDE) with technical success (1/33 patients) but clinical failure had additional treatment directly sclerosing the TD under computed tomography scan. Cervical fluid collection sclerotherapy was done in 7 patients as an additional treatment. Resolution of the chyle leak after procedures was observed in all patients (100%). The mean time to resolution was 3 days (1– 7 days). There was no complication intra and after procedures. Conclusion: TDE, selective TD branches embolization and TDD are safe and effective minimally invasive treatments for CL post-surgery for thyroid carcinoma. Sclerosing cervical fluid collection contributes to clinical success. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Adjunct role of liquid absolute alcohol intralesional sclerotherapy during the surgical management of spinal primary aneurysmal bone cyst in a child: a technical case report.
- Author
-
Sharma, Rajeev, Goyal, Sarvesh, and Laythalling, Rajinder Kumar
- Subjects
- *
SCLEROTHERAPY , *ANEURYSMAL bone cyst , *TECHNICAL reports , *BLOOD volume , *ALCOHOL , *PEDIATRIC surgery - Abstract
Background: Aneurysmal bone cyst is composed of variable -sized cystic blood-filled spaces separated by connective tissue septae. First-line surgical resection of spinal aneurysmal bone cyst in a child with limited total blood volume can lead to massive intraoperative bleeding, thus limiting extent of resection. Our Centre's has good experience of using absolute alcohol as an effective immediate devascularizing agent during vertebral hemangioma surgery in children. Material and methods: We report the first case of pediatric lumbar primary aneurysmal bone cyst in which completely blood-less piecemeal total resection of the lesion was performed after intraoperative absolute alcohol intralesional sclerotherapy. Results: Completely blood-less piecemeal total resection of the lumbar aneurysmal bone cyst was performed after intraoperative absolute alcohol intralesional sclerotherapy. Conclusion: Intraoperative absolute alcohol intralesional sclerotherapy is a very effective devascularizing adjunct for complete piecemeal resection of spinal aneurysmal bone cyst in children with limited blood volume. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Our Experience at Tertiary Medical College: Excision with Sublabial Approach Versus Marsupialization with Transnasal Endoscopic Approach in Patients with Nasolabial Cyst.
- Author
-
Mane, Balaji Shankarrao and Gavali, Rushali Madhukar
- Subjects
- *
MEDICAL schools , *CYSTS (Pathology) , *SCLEROTHERAPY , *VISUAL analog scale , *POSTOPERATIVE pain - Abstract
Rare non-odontogenic cysts of the soft tissue of the midface that form between the nasal vestibule and upper lip are known as nasolabial cysts. Treatment can be accomplished by surgical removal, injection of sclerosing material into the cyst, and endoscopic marsupialization. The aim of this study is to compare the effectiveness of Excision with sublabial approach versus Marsupialization with Transnasal Endoscopic approach in patients with Nasolabial cyst in terms of operating time, recurrence rate, postoperative pain and complications. Our study was Duration based prospective observational study with a Duration of four years from August 2018 till July 2022 with study population inclusive of 30 patients aged between 20 and 70 years who were diagnosed with a unilateral nasolabial cyst on the basis of clinical presentation, anatomical location, and computed tomography (CT) findings at ENT Department of our Tertiary Institution. The study used a randomized, single blind, parallel design with a total of 30 patients, which were randomly allocated to undergo Excision with sublabial approach (group A) in 15 patients (15 nasolabial cysts) and Marsupialization with Transnasal Endoscopic approach (Group B) in 15 patients (15 Nasolabial cysts). In the sublabial approach group, the mean operating time was 91.28 ± 3.1 min, whereas in the transnasal marsupialization group, it was 29.7 ± 3.2 min. These differences were statistically significant (P = 0.003). In the excision with sublabial approach and transnasal endoscopic marsupialization groups, the visual analogue scale (VAS) for postoperative pain was 5.9 ± 1.4 and 3.2 ± 0.6, respectively (P = 0.001). Ten patients in the sublabial approach group and five patients in the transnasal marsupialization group had one or more problems during the follow-up period which disappeared spontaneously within 4 weeks without long lasting issues. There were no recurrence lesions or obstructions of the marsupialized cyst opening in either group, according to physical, endoscopic and computed tomography examinations. Nasolabial cysts can be marsupialized transnasally, which offers many advantages over the more traditional sublabial excision method. Transnasal endoscopic marsupialization has the benefits of a shorter operating time, less postoperative pain, and a low complication rate. Therefore, we propose that Transnasal Endoscopic marsupialization be the treatment of choice for nasolabial cyst, replacing the conventional Excision with sublabial approach. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Cohort Studies to Study the Efficacy of Ultrasound-Guided Foam Sclerotherapy for Varicose Vein Treatment.
- Author
-
Karimian, Mohammad, Mohammadi, Younes, Tardeh, Samira, and Tardeh, Zeinab
- Subjects
- *
LEG , *SCIENTIFIC observation , *ULTRASONIC imaging , *VARICOSE veins , *TREATMENT effectiveness , *META-analysis , *RANDOMIZED controlled trials , *DESCRIPTIVE statistics , *RADIO frequency therapy , *SCLEROTHERAPY , *SYSTEMATIC reviews , *LONGITUDINAL method , *QUALITY of life , *CONFIDENCE intervals , *CATHETER ablation - Abstract
Varicose veins are common disorders that affect the quality of life of sufferers due to the symptoms they cause. The efficacy of different varicose vein treatments has been studied extensively, with varying success rates. Less invasive treatments, such as sclerotherapy, can be mentioned among the proposed therapies. This study investigates the efficacy of ultrasound-guided foam sclerotherapy (UGFS) for treating varicose veins. In this study, the results were reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines of the Meta-analysis of Observational Studies in Epidemiology (MOOSE) protocol. By searching in 11 databases as well as the Google Scholar search engine using the keywords "varicose vein," "foam sclerotherapy," "occlusion," "success," "Duplex-guided foam sclerotherapy," "efficacy," and "Ultrasound-Guided Foam Sclerotherapy," randomized clinical trial (RCT) and cohort articles published until July 2022 were collected. The required information was extracted and analyzed using Comprehensive Meta-analysis (CMA) software version 2. Data analysis of 35 randomized clinical trial articles showed that the success rate of ultrasound-guided foam sclerotherapy in the treatment of varicose veins is 78% (95% CI: 73–83; P value < 0.001) (I2 = 89.11, P value < 0.001). The subgroup analysis showed that the success of this method is more in the form of sodium tetradecyl sulfate and polidocanol 2% foam and in a period of fewer than 3 months from the start of treatment and in the Asian race. Also, the analysis of 8 cohort studies showed that the success rate of ultrasound-guided foam sclerotherapy in the treatment of varicose veins is 81% (95% CI: 65–91; P value < 0.001). The most prevalent complications of this method in the treatment of varicose veins were induration, thrombophlebitis, bruising, dyspigmentation, hematoma, pain, and phlebitis. Present study illustrated that the effectiveness of ultrasound-guided foam sclerotherapy in the treatment of varicose veins is high. However, it was significantly less successful than published meta-analyses on other less invasive methods such as radiofrequency ablation (RFA) and endovenous laser ablation (EVLA). Also, this method showed more major complications than our previous study on the effect of endovenous laser ablation in the treatment of varicose veins. Factors such as foam type, follow-up duration, and racial differences can affect the study's results. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Embolic Agents: Sclerotherapy.
- Author
-
Lim, Christina, Lee, Sean, Ghosh, Abheek, and Funaki, Brian
- Subjects
- *
PATIENT selection , *PATIENT safety , *ARTERIOVENOUS malformation , *THERAPEUTIC embolization , *VARICOSE veins , *SCLEROTHERAPY , *DRUG efficacy - Published
- 2024
- Full Text
- View/download PDF
39. CORRELATION OF VARIOUSCLINICALASSESSMENT SCORES WITH SURGICAL OUTCOME IN VARICOSE VEINS OF LOWER LIMBS.
- Author
-
Nagaraj, Jeevan, N. K., Vedavathi, and A., Tanmay
- Subjects
- *
VARICOSE veins , *PEARSON correlation (Statistics) , *VEIN surgery , *SCLEROTHERAPY , *SURGICAL complications , *SYMPTOMS - Abstract
BACKGROUND: Varicose vein entity includes a vast majority of clinical and pathological manifestations. However, there are very few standardized methods to assess the clinical severity and predict the outcomes of surgery in such patients. Hence, this current study evaluated the role of on Clinical Assessment of varicose veins by clinical scores and correlating the outcomes of surgery in such patients. METHODS AND MATERIALS: This analytical study group consisted of 60 patients above 18 years. They were assessed for severity of varicose veins by documenting a detailed history, clinical examination findings, imaging studieson a prestructured case sheet and the result of surgery. It wasfound that majority of the patients were =60 yrs.and the left lowerlimb was predominantly affected in both sexes. RESULTS: In our study 50 % (n=30) patients had Severe grade of Venous Reflux (VRS). We found that majority had undergone the SFJ Flush ligation and multiple perforator ligation 50.0% (n=30). We also analyzed the postoperative outcome, which revealed majority had uneventful periods 66.67 % (n=40). We also found that the clinical features assessed correlated well with the venous reflux on the Duplex scan, as well as surgical outcomes and complications (Pearson correlation coefficient=0.171, P value-0.032). CONCLUSION- A statistically significant result was found for the clinical assessment scores and also correlated with the surgical outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2024
40. Sclerotherapy of a Symptomatic Renal Cyst.
- Author
-
Orbay, Tuğçe Merve, Özer, Hamza, and Moralıoğlu, Serdar
- Subjects
- *
CYTOLOGY , *HYPERTENSION , *ETHANOL , *ULTRASONIC imaging , *TREATMENT effectiveness , *CYSTIC kidney disease , *SCLEROTHERAPY , *INJECTIONS , *CATHETERS , *MEDICAL drainage , *FLUOROSCOPY , *THERAPEUTICS , *DISEASE complications - Abstract
Simple renal cysts are not commonly found in children. They occur in a small percentage of cases, with an incidence of 0.2%-0.5%. These cysts are typically solitary and develop in the renal cortex. Pain, infection, hematuria, hypertension, or obstruction of the collecting system are indications for treatment. When intervention is necessary, there are several ways to reduce cyst volume. In this report, we discuss the pediatric case of a solitary giant renal cyst and its therapeutic approach. We present a symptomatic pediatric renal cyst patient treated with a sclerosing agent. A simple renal cyst is a rare condition in children, and its treatment includes conservative management, percutaneous sclerosing agent injection, and surgical approach. Choosing the appropriate treatment according to the patient’s condition and clinical symptoms is essential. We think that sclerotherapy should be the first-line therapy before surgery in symptomatic simple renal cysts. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Management of bleeding varicose veins.
- Author
-
Tan, Matthew, Campbell, Bruce, Parsi, Kurosh, and Davies, Alun H
- Subjects
- *
HEMORRHAGE risk factors , *HEMORRHAGE treatment , *HEMORRHAGE prevention , *MEDICAL protocols , *RISK assessment , *PATIENT education , *FIRST aid in illness & injury , *COMPRESSION bandages , *INTERNATIONAL agencies , *VARICOSE veins , *SCLEROTHERAPY , *LIFE support systems in critical care , *COMPRESSION therapy , *DISEASE relapse , *HEMORRHAGE , *DISEASE complications ,MORTALITY risk factors - Abstract
The article focuses on the management of bleeding varicose veins, highlighting the potential risks and urgent need for medical attention. Topics discussed include first aid measures for patients experiencing bleeding, immediate clinical management in healthcare facilities, and the importance of timely referral to vascular specialists to prevent recurrence and ensure patient safety.
- Published
- 2024
- Full Text
- View/download PDF
42. Coagulation with hemostatic forceps after endoscopic injection sclerotherapy in a pediatric patient with esophageal varices.
- Author
-
Nakamura, Jun, Hikichi, Takuto, and Tanaka, Hideaki
- Subjects
- *
CHILD patients , *ESOPHAGEAL varices , *SCLEROTHERAPY , *COAGULATION , *INJECTIONS , *FORCEPS - Abstract
Watch a video of this article. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Sclerotherapy for hemorrhoidal disease: systematic review and meta-analysis.
- Author
-
Gallo, G., Picciariello, A., Armellin, C., Lori, E., Tomasicchio, G., Di Tanna, G. L., Santoro, G. A., Alharbi, M., Sorrenti, S., and Grossi, U.
- Subjects
- *
SCLEROTHERAPY , *ANALGESIA , *RECORDING & registration - Abstract
Background: This systematic review and meta-analysis aimed to evaluate the safety and efficacy of sclerotherapy methods for hemorrhoidal disease (HD) over the past 40 years. Methods: The review followed the 2020 Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. A comprehensive literature search was conducted, including studies reporting the use of sclerotherapy in patients with HD. Study eligibility criteria were defined, and data were extracted independently by the authors. Random-effects meta-analyses were performed to assess outcomes of interest. Results: Out of 1965 records identified, 44 studies met the inclusion criteria, involving 9729 patients. The majority of studies were conducted in Japan, followed by the UK, Italy, and Portugal. The median age of participants was 52 years, and the majority were male. The Goligher grade distribution indicated varying degrees of HD severity. Sclerotherapy was predominantly administered through anoscopy, with polidocanol being the most commonly used agent. The procedure was generally performed without pre-injection analgesia. The meta-analysis of 14 randomized controlled trials (RCTs) revealed that sclerotherapy was not inferior to control interventions in terms of success rate (risk ratio [RR] 1.00, 95% CI 0.71–1.41) and recurrence rate (RR 1.11, 95% CI 0.69–1.77), while resulting in fewer complications (RR 0.46, 95% CI 0.23–0.92). Conclusions: This systematic review highlights the safety and efficacy of sclerotherapy for HD, which yields similar success rates and fewer complications compared to other conservative or surgical approaches. Further research is warranted to optimize sclerotherapy techniques and evaluate long-term outcomes. Registration: PROSPERO 2023 CRD42023396910. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Symptomatic Liver Cyst Successfully Treated with Transgastric Drainage and Sclerotherapy Using Minocycline Hydrochloride.
- Author
-
Yoshitomi, Kengo, Koya, Yudai, Miyagawa, Koichiro, Maruno, Yuki, Yamaguchi, Koki, Taniguchi, Ryuta, Onitsuka, Koji, Sakamoto, Yoshitaka, Oe, Shinji, and Harada, Masaru
- Subjects
- *
SCLEROTHERAPY , *TREATMENT effectiveness , *CYSTS (Pathology) , *LIVER , *MINOCYCLINE , *PERIODIC health examinations , *GASTRIC outlet obstruction , *LIVER abscesses - Abstract
A liver cyst is hepatic fluid-filled cavities often detected in clinical surveillances such as a health examination. Although the liver cyst is usually asymptomatic and observed without any therapeutic intervention, it can be symptomatic and needs treatment due to its enlargement, hemorrhage, and infection. A 74-year-old woman presented with upper abdominal pain and a huge liver cyst in the left lobe. Several examinations including image findings revealed that the symptom could be derived from the liver cyst. Although there is no definite guideline of treatment for symptomatic liver cysts, percutaneous ultrasound-guided drainage with sclerotherapy or surgery is often selected. Because of anatomical accessibility to the liver cyst and the patient's wish, we performed endoscopic transgastric drainage with insertion of both an internal stent and an external nasocystic tube. Sclerotherapy with minocycline hydrochloride was performed through the nasocystic tube, and the liver cyst shrunk completely without any complications. This is the first reported method of administering minocycline hydrochloride through a nasocystic tube, which can be a therapeutic option for patients with symptomatic liver cysts. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. The Efficacy and Safety of Transvaginal Ethanol Sclerotherapy in the Treatment of Endometrial Cysts—A Systematic Review.
- Author
-
Frankowska, Karolina, Dymanowska-Dyjak, Izabela, Abramiuk, Monika, and Polak, Grzegorz
- Subjects
- *
ETHANOL , *SCLEROTHERAPY , *OVARIAN reserve , *CYSTS (Pathology) , *PREGNANCY outcomes , *REPRODUCTIVE technology - Abstract
Endometriosis, as a chronic disorder that is a source of severe pain ailments and infertility, requires a comprehensive therapeutic approach. Sclerotherapy, consisting of the administration of sclerosing agents into the cyst, is a constantly evolving minimally invasive treatment method for this disease. Hence, the main objective of this systematic review was to evaluate the impact of its most often used variant, transvaginal ethanol sclerotherapy, on endometriosis-related symptoms, endometrial cyst recurrence rate, ovarian reserve, assisted reproductive technology (ART) outcomes, and pregnancy outcomes, as well as to assess potential complications resulting from this treatment. This systematic review was undertaken using PubMed, Scopus, Web of Science, and Cochrane Library databases on 24 November 2023. The risk of bias in included studies was assessed with the use of the Newcastle–Ottawa scale (NOS) and the revised Cochrane risk of bias 2.0 tool for randomized controlled trials. From the 1141 records obtained from all databases, 16 studies have been included in this review. The use of ethanol sclerotherapy was characterized by a low rate of post-procedural complications. The recurrence rate of endometrial cysts after the procedure depended on the ethanol instillation time within the cyst. Although ethanol sclerotherapy had negligible influence on ovarian reserves when compared to laparoscopic cystectomy, the effects of both these methods on pregnancy outcomes were comparable. This review identifies that sclerotherapy is safe, provides significant relief of symptoms, and does not impair the reproductive potential of the patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Sclerotherapy for hemorrhoidal disease: systematic review and meta-analysis.
- Author
-
Gallo, G., Picciariello, A., Armellin, C., Lori, E., Tomasicchio, G., Di Tanna, G. L., Santoro, G. A., Alharbi, M., Sorrenti, S., and Grossi, U.
- Abstract
Background: This systematic review and meta-analysis aimed to evaluate the safety and efficacy of sclerotherapy methods for hemorrhoidal disease (HD) over the past 40 years. Methods: The review followed the 2020 Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. A comprehensive literature search was conducted, including studies reporting the use of sclerotherapy in patients with HD. Study eligibility criteria were defined, and data were extracted independently by the authors. Random-effects meta-analyses were performed to assess outcomes of interest. Results: Out of 1965 records identified, 44 studies met the inclusion criteria, involving 9729 patients. The majority of studies were conducted in Japan, followed by the UK, Italy, and Portugal. The median age of participants was 52 years, and the majority were male. The Goligher grade distribution indicated varying degrees of HD severity. Sclerotherapy was predominantly administered through anoscopy, with polidocanol being the most commonly used agent. The procedure was generally performed without pre-injection analgesia. The meta-analysis of 14 randomized controlled trials (RCTs) revealed that sclerotherapy was not inferior to control interventions in terms of success rate (risk ratio [RR] 1.00, 95% CI 0.71–1.41) and recurrence rate (RR 1.11, 95% CI 0.69–1.77), while resulting in fewer complications (RR 0.46, 95% CI 0.23–0.92). Conclusions: This systematic review highlights the safety and efficacy of sclerotherapy for HD, which yields similar success rates and fewer complications compared to other conservative or surgical approaches. Further research is warranted to optimize sclerotherapy techniques and evaluate long-term outcomes. Registration: PROSPERO 2023 CRD42023396910. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Patient characteristics and disease spectrum in a German vascular anomalies center.
- Author
-
Strübing, Felix, Laurich, Annette, Weiss, Christel, Kneser, Ulrich, Schoenberg, Stefan, and Sadick, Maliha
- Subjects
- *
COMPRESSION garments , *COMPRESSION therapy , *RARE diseases , *SURGICAL excision , *SCLEROTHERAPY - Abstract
Background: Vascular malformations are rare diseases that should be treated in dedicated vascular anomaly centers (VAC). There is only a small amount of data on the diagnostic and therapeutic handling of these patients, before they are referred to a VAC. Purpose: To demonstrate the disease-specific patient characteristics in a German VAC, which are required to determine diagnostic and therapeutic steps. Material and Methods: In a retrospective study, all patients who were treated in the VAC from April 2014 until August 2021 were identified. In total, 593 patients were included in this study. Results: Almost all patients had previously consulted a physician (591/593, 99.7%). A mean of two different physicians had been consulted (range 0–10). Patients with more complex, syndromal vascular malformations had significantly more previous appointments (P = 0.0018). In only 44% (261/593) of patients, the referral diagnosis was made correctly. Most patients had been previously treated for their vascular anomaly: pharmacotherapy (n = 130; 21.9%), compression garments (n = 141; 23.8%), surgical resection (n = 80; 17.3%) and sclerotherapy (n = 68; 11.5%). Fifty-two patients who had been falsely diagnosed had also received therapy prior to their referral to the VAC (8.8%). Most patients received an ultrasound examination in the VAC (n = 464; 78.2%). Most frequently, compression therapy was prescribed (n = 256; 43.2%), followed by sclerotherapy (n = 175, 29.5%) and pharmacotherapy (n = 55; 9.3%). Conclusion: Patients suffering from vascular anomalies often go through a complicated scheduling with numerous outpatient appointments and have a high risk of misdiagnosis and mistreatment prolonging the medical condition. Therefore, patients with vascular anomalies should be treated in a dedicated vascular anomaly center. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Sclerotherapy with intralesional bleomycin injection under guidance of multi-slice CT for retrobulbar orbital low-flow vascular lesions—single-center experience.
- Author
-
Lin, Shin-Nan, Wu, Yi-Ming, Siow, Tiing-Yee, Yeh, Chih-Hua, Toh, Cheng-Hong, Tseng, Ti-Yung, and Wong, Ho-Fai
- Subjects
- *
BLEOMYCIN , *SCLEROTHERAPY , *PATIENTS , *LYMPHATIC abnormalities , *COMPUTED tomography , *SPIRAL computed tomography - Abstract
Objective This study investigated the safety and efficacy of sclerotherapy with intralesional bleomycin injection (IBI) for retrobulbar orbital low-flow vascular lesions under multi-slice computed tomography (CT) guidance. Methods Between January 2010 and September 2021, consecutive patients with retrobulbar orbital low-flow vascular lesions who underwent CT-guided IBI at a tertiary centre in Taiwan were enrolled. Their medical records and imaging data were retrospectively collected. Results This study enrolled 13 patients (7 male and 6 female patients; age range: 1-57 years; mean age: 25.9 years) with lymphatic malformation (LM, n = 4), venolymphatic malformation (n = 1), and venous malformation (VM, n = 8). The overall radiological response rate was 76.9% (10 of 13); the radiological response rate was 75.0% in the VM group (6 of 8) and 75.0% in the LM group (3 of 4). Moreover, 3 patients (23.1%) had minor complications and 1 (7.7%) had a major complication. The mean clinical and radiological follow-up was 8.3 months and no recurrence or progression was reported. Conclusion CT-guided IBI is an effective and relatively safe minimally invasive treatment for retrobulbar orbital low-flow vascular lesions, with an overall radiological response rate of 76.9% in a mean of 1.5 sessions and a low complication rate. Advances in knowledge CT-guided sclerotherapy with IBI is a relatively safe, effective, and feasible alternative treatment option for retrobulbar orbital low-flow vascular lesions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Malformación linfática quística gigante del hígado: dos casos pediátricos con diferente abordaje quirúrgico.
- Author
-
Villamil-Martínez, Ramón, Ramírez-Guirado, Alejandro, Betancourt-Berriz, Daniela, and Alfonso-González, Beatriz
- Subjects
- *
LYMPHATIC abnormalities , *SCLEROTHERAPY , *LYMPHANGIOMAS , *HEPATOMEGALY , *HEPATECTOMY - Abstract
Introduction: Cystic lymphatic malformations, also called cystic lymphangiomas, are very rarely found in the liver. Clinical cases. Two pediatric female preschool-age patients. presented with hepatomegaly due to multi-septated cystic lesions of the liver, who received treatment at Hospital Pediátrico Universitario William Soler, La Habana, Cuba. Results: We report two pediatric cases with giant cystic lymphatic malformation of the liver. In both cases, the diagnosis were based on imaging, laparoscopy and pathology. In one case the treatment was right hepatectomy, whereas in the other, sclerotherapy was performed, both with a favorable outcome. Conclusion: Despite its rarity, this diagnosis should be considered in pediatric patients with hepatic cystic lesions. The recommended treatment is surgical resection, but its indication and extent should be assessed individually for each patient. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Management of Benign Ovarian Cyst with Ultrasound-Guided Aspiration and Sclerotherapy.
- Author
-
Riaz, Adeel, Saeed, Mahwish Zohra, and Ahmed, Saima
- Subjects
- *
OVARIAN cysts , *SCLEROTHERAPY - Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.